Fig. 3From: Role of sodium/glucose cotransporter inhibition on a rat model of angiotensin II–dependent kidney damageSodium-glucose cotransporter mRNA expression (a) and Immunoblotting (b) in rats infused for 2 weeks with vehicle (Control), Ang II (Ang), Angiotensin II plus Losartan treatment (Los) and Ang II plus Empagliflozin treatment (Emp). Each bar represents the mean ± SE of 5 different rats for each experimental group, * p < 0.05 compared vs vehicle, + p < 0.05 compared vs Ang IIBack to article page